comparemela.com

Latest Breaking News On - Biopharmaceutical industry - Page 8 : comparemela.com

Insider Sell Alert: Chief Scientific Officer Jude Onyia Sells Shares of Neurocrine Biosciences Inc

Neurocrine Biosciences Inc (NASDAQ:NBIX), a prominent player in the biopharmaceutical industry, has recently witnessed a significant insider sell event.

Jude onyiaNeurocrine biosciences incChief scientific officer jude onyiaNeurocrine biosciencesInsider tradingChief scientific officerBiopharmaceutical industryNsider transactionsIopharmaceutical company

The Royalty Pharma PLC (RPRX) Company: A Short SWOT Analysis

Decoding Royalty Pharma PLC (RPRX): A Strategic SWOT Insight

Royalty pharmaRobust portfolioCapital efficiencyKey productsDebt exposureIndustry growthMarket risksBiopharmaceutical industryDiversified portfolioCommercial productsMarket risksTherapeutic areasIntense competitionThe company

Hainan Boao Hope City Pioneering Unique Medical Policies and Driving Collaboration with Denmark s Biopharmaceutical Industry

Hainan, CHINA – Media OutReach – 30 October 2023 – From 12th to 13th October, a delegation from Hainan Province, organised by the Hainan Provincial .

Hainan provinceDriving collaborationBiopharmaceutical industryMedia outreachHainan provincial governmentDenmark s

Contract Research Organization (CRO) Market to grow by USD 52 46 billion from 2022 to 2027, the market is fragmented due to the presence of prominent companies like BioAgile Therapeutics Pvt Ltd, Ergomed Plc and Laboratory Corp of America Holdings -, and many more - Technavio

NEW YORK, Oct. 24, 2023 /PRNewswire/ — The contract research organization (CRO) market is estimated to grow by USD 52.46 billion from 2022 to 2027, growing at a CAGR of 11.75%. The contract research organization (CRO) market is fragmented owing to the presence of many global and regional companies. A few prominent companies that offer contract research organization […]

United statesUnited kingdomJesse maidaClinical trial serviceConsulting incHoldings incAmerica holdingsNovotech health holdingsLaboratory corpService typeThermo fisher scientific incGeneticist incSyneos health incErgomed plcClinical coWuxi apptec co

Insider Sell: CFO Andrew Dickinson Sells 5,000 Shares of Gilead Sciences Inc

On October 17, 2023, Andrew Dickinson, the Chief Financial Officer (CFO) of Gilead Sciences Inc (NASDAQ:GILD), sold 5,000 shares of the company.

Gilead sciences incGurufocus valueAndrew dickinsonInsider tradingBiopharmaceutical industry

vimarsana © 2020. All Rights Reserved.